The company said Sept. 30 that 12 lots are being recalled, all of which were manufactured between Jan. 10 and June 15.
Exposure to benzene can cause an increased risk of cancers, including leukemia, blood cancer of the bone marrow and other potentially life-threatening blood disorders depending on the level and extent of exposure.
Coppertone didn’t specify the level of benzene found in its products, but said that daily exposure to the levels detected in the recalled sunscreen products isn’t expected to cause adverse health effects. The company said it is recalling the lots out of an abundance of caution, and hasn’t received any reports of adverse events.
Read the full news release here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
